These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 18627093)
41. Upregulation of cellular triacylglycerol - free fatty acid cycling by oleate is associated with long-term serum-free survival of human breast cancer cells. Przybytkowski E; Joly E; Nolan CJ; Hardy S; Francoeur AM; Langelier Y; Prentki M Biochem Cell Biol; 2007 Jun; 85(3):301-10. PubMed ID: 17612624 [TBL] [Abstract][Full Text] [Related]
42. Monitoring system of cell's viability and function for bioartificial liver support system. Lou H; Li M; Xiang H; Liu J; Yang W Conf Proc IEEE Eng Med Biol Soc; 2005; 2005():6598-601. PubMed ID: 17281783 [TBL] [Abstract][Full Text] [Related]
43. Applied Hepatic Bioengineering: Modeling the Human Liver Using Organoid and Liver-on-a-Chip Technologies. Telles-Silva KA; Pacheco L; Komatsu S; Chianca F; Caires-Júnior LC; Araujo BHS; Goulart E; Zatz M Front Bioeng Biotechnol; 2022; 10():845360. PubMed ID: 35237587 [TBL] [Abstract][Full Text] [Related]
44. End-stage liver failure: filling the treatment gap at the intensive care unit. Chamuleau RAFM; Hoekstra R J Artif Organs; 2020 Jun; 23(2):113-123. PubMed ID: 31535298 [TBL] [Abstract][Full Text] [Related]
45. Challenges and Opportunities in the Design of Liver-on-Chip Microdevices. Ehrlich A; Duche D; Ouedraogo G; Nahmias Y Annu Rev Biomed Eng; 2019 Jun; 21():219-239. PubMed ID: 31167098 [TBL] [Abstract][Full Text] [Related]
47. A glycosaminoglycan based, modular tissue scaffold system for rapid assembly of perfusable, high cell density, engineered tissues. Tiruvannamalai-Annamalai R; Armant DR; Matthew HW PLoS One; 2014; 9(1):e84287. PubMed ID: 24465401 [TBL] [Abstract][Full Text] [Related]
48. A microfluidic hepatic coculture platform for cell-based drug metabolism studies. Novik E; Maguire TJ; Chao P; Cheng KC; Yarmush ML Biochem Pharmacol; 2010 Apr; 79(7):1036-44. PubMed ID: 19925779 [TBL] [Abstract][Full Text] [Related]
49. Extracorporeal plasma perfusion of cultured hepatocytes: effect of intermittent perfusion on hepatocyte function and morphology. Stefanovich P; Matthew HW; Toner M; Tompkins RG; Yarmush ML J Surg Res; 1996 Nov; 66(1):57-63. PubMed ID: 8954832 [TBL] [Abstract][Full Text] [Related]
50. Metabolic pre-conditioning of cultured cells in physiological levels of insulin: generating resistance to the lipid-accumulating effects of plasma in hepatocytes. Chan C; Berthiaume F; Washizu J; Toner M; Yarmush ML Biotechnol Bioeng; 2002 Jun; 78(7):753-60. PubMed ID: 12001167 [TBL] [Abstract][Full Text] [Related]
51. Optimization of rat hepatocyte culture in citrated human plasma. Washizu J; Berthiaume F; Chan C; Tompkins RG; Toner M; Yarmush ML J Surg Res; 2000 Oct; 93(2):237-46. PubMed ID: 11027466 [TBL] [Abstract][Full Text] [Related]
52. Biotransformation of diazepam in a clinically relevant flat membrane bioreactor model using primary porcine hepatocytes. Maringka M; Giri S; Nieber K; Acikgöz A; Bader A Fundam Clin Pharmacol; 2011 Jun; 25(3):343-53. PubMed ID: 20618872 [TBL] [Abstract][Full Text] [Related]
53. Effects of plasma exposure on cultured hepatocytes: Implications for bioartificial liver support. Matthew HW; Sternberg J; Stefanovich P; Morgan JR; Toner M; Tompkins RG; Yarmush ML Biotechnol Bioeng; 1996 Jul; 51(1):100-11. PubMed ID: 18627093 [TBL] [Abstract][Full Text] [Related]